【蛋白質】蛋白質藥物發現《Nabla》完成2,600萬美元A輪，由Radical Ventures領投

 【蛋白質】蛋白質藥物發現《Nabla》完成2,600萬美元A輪，由Radical Ventures領投

 文章出處  

Businesswire 

 

 原文標題  

Nabla Bio Secures $26M Series A Financing and Collaborations with AstraZeneca, Bristol Myers Squibb and Takeda for Generative Protein Design 

 

 Twitter  

https://twitter.com/aimedadviser/status/1790717878318346405 

 

 文章序號  

5584 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2024 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.